Cansortium Inc
FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, edibles, and other accessories under the Flue… Read more
Cansortium Inc (CNTMF) - Total Assets
Latest total assets as of September 2025: $203.63 Million USD
Based on the latest financial reports, Cansortium Inc (CNTMF) holds total assets worth $203.63 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cansortium Inc - Total Assets Trend (2016–2024)
This chart illustrates how Cansortium Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cansortium Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Cansortium Inc's total assets of $203.63 Million consist of 29.7% current assets and 70.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.2% |
| Accounts Receivable | $422.00K | 0.2% |
| Inventory | $18.32 Million | 8.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $37.59 Million | 18.2% |
| Goodwill | $1.52 Million | 0.7% |
Asset Composition Trend (2016–2024)
This chart illustrates how Cansortium Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cansortium Inc's current assets represent 29.7% of total assets in 2024, an increase from 25.0% in 2016.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2024, down from 21.8% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 18.2% of total assets.
Cansortium Inc Competitors by Total Assets
Key competitors of Cansortium Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Cansortium Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Cansortium Inc generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cansortium Inc is currently not profitable relative to its asset base.
Cansortium Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 0.23 | 0.23 |
| Quick Ratio | 0.77 | 0.10 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $13.34 Million | $ -95.45 Million | $ -53.55 Million |
Cansortium Inc - Advanced Valuation Insights
This section examines the relationship between Cansortium Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.65 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 16.4% |
| Total Assets | $206.99 Million |
| Market Capitalization | $22.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cansortium Inc's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cansortium Inc's assets grew by 16.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cansortium Inc (2016–2024)
The table below shows the annual total assets of Cansortium Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $206.99 Million | +16.42% |
| 2023-12-31 | $177.80 Million | -0.13% |
| 2022-12-31 | $178.03 Million | -2.43% |
| 2021-12-31 | $182.46 Million | +18.07% |
| 2020-12-31 | $154.53 Million | -7.50% |
| 2019-12-31 | $167.07 Million | +18.94% |
| 2018-12-31 | $140.47 Million | +675.97% |
| 2017-12-31 | $18.10 Million | +198.01% |
| 2016-12-31 | $6.07 Million | -- |